4-methyl-1-[3-(methylaminomethyl)-1,2,3,4-tetrahydroisoquinolin-5-yl]piperidin-4-amine;5,6,7,8-tetrahydroquinoline
C26H39N5 — CID 142417004
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-methyl-1-[3-(methylaminomethyl)-1,2,3,4-tetrahydroisoquinolin-5-yl]piperidin-4-amine;5,6,7,8-tetrahydroquinoline
4-methyl-1-[3-(methylaminomethyl)-1,2,3,4-tetrahydroisoquinolin-5-yl]piperidin-4-amine;5,6,7,8-tetrahydroquinoline (PubChem CID 142417004) has the molecular formula C26H39N5 and a molecular weight of 421.63 g/mol. Its IUPAC name is 4-methyl-1-[3-(methylaminomethyl)-1,2,3,4-tetrahydroisoquinolin-5-yl]piperidin-4-amine;5,6,7,8-tetrahydroquinoline.
Molecular Properties
| Compound Name | 4-methyl-1-[3-(methylaminomethyl)-1,2,3,4-tetrahydroisoquinolin-5-yl]piperidin-4-amine;5,6,7,8-tetrahydroquinoline |
|---|---|
| PubChem CID | 142417004 |
| Molecular Formula | C26H39N5 |
| Molecular Weight | 421.63 g/mol |
| Exact Mass | 421.32 |
| IUPAC Name | 4-methyl-1-[3-(methylaminomethyl)-1,2,3,4-tetrahydroisoquinolin-5-yl]piperidin-4-amine;5,6,7,8-tetrahydroquinoline |
| SMILES | CNCC1Cc2c(cccc2N2CCC(C)(N)CC2)CN1.c1cnc2c(c1)CCCC2 |
| InChI | InChI=1S/C17H28N4.C9H11N/c1-17(18)6-8-21(9-7-17)16-5-3-4-13-11-20-14(12-19-2)10-15(13)16;1-2-6-9-8(4-1)5-3-7-10-9/h3-5,14,19-20H,6-12,18H2,1-2H3;3,5,7H,1-2,4,6H2 |
| InChIKey | RUHWBAJGLLJSAY-UHFFFAOYSA-N |
| XLogP | 3.20 |
| TPSA | 66.21 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 421.63 |
| LogP ≤ 5 | 3.20 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142417004 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.